Gerald PhD McMahon Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Gerald PhD McMahon.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gerald PhD McMahon. Gerald PhD McMahon is Chief Executive Officer in PONIARD PHARMACEUTICALS, INC. ($NERX) and Director in Celldex Therapeutics, Inc. ($AVAN) and Director in OXIGENE INC ($OXGN) and President and CEO in Harpoon Therapeutics, Inc. ($HARP).
Latest Insider Trading Transactions of Gerald PhD McMahon
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CLDX, HARP, MATN, NERX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 29 2021 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | A | 18.66 | 181,470 | 3,386,230 | 181,470 | |
| Feb 04 2020 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | A | 13.29 | 165,210 | 2,195,641 | 165,210 | |
| Sep 06 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Option Exercise | M | 0.60 | 169,462 | 101,677 | 318,590 | |
| Sep 06 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | M | 0.60 | 169,462 | 101,677 | 172,462 | 3 K to 172.5 K (+5,648.73 %) |
| May 16 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.16 | 1,000 | 10,157 | 3,000 | 2 K to 3 K (+50.00 %) |
| May 10 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.56 | 1,000 | 10,559 | 2,000 | 1,000 to 2 K (+100.00 %) |
| May 07 2019 | HARP | Harpoon Therapeuti ... | McMahon Gerald PhD | President and CEO | Buy | P | 10.53 | 1,000 | 10,530 | 1,000 | 0 to 1,000 |
| Dec 04 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.30 | 2,824 | 843 | 180,697 | 183.5 K to 180.7 K (-1.54 %) |
| Nov 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.31 | 2,888 | 908 | 183,521 | 186.4 K to 183.5 K (-1.55 %) |
| Oct 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.45 | 2,888 | 1,302 | 186,409 | 189.3 K to 186.4 K (-1.53 %) |
| Sep 05 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.50 | 2,813 | 1,412 | 189,297 | 192.1 K to 189.3 K (-1.46 %) |
| Aug 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.47 | 2,813 | 1,308 | 192,110 | 194.9 K to 192.1 K (-1.44 %) |
| Jul 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.50 | 2,813 | 1,417 | 194,923 | 197.7 K to 194.9 K (-1.42 %) |
| Jun 15 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 0.60 | 67,000 | 40,274 | 67,000 | |
| Jun 04 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.58 | 2,813 | 1,632 | 197,736 | 200.5 K to 197.7 K (-1.40 %) |
| May 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 0.74 | 2,813 | 2,082 | 200,549 | 203.4 K to 200.5 K (-1.38 %) |
| Apr 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.33 | 3,379 | 7,873 | 203,362 | 206.7 K to 203.4 K (-1.63 %) |
| Mar 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.25 | 3,415 | 7,684 | 206,741 | 210.2 K to 206.7 K (-1.62 %) |
| Feb 02 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.76 | 3,415 | 9,425 | 210,156 | 213.6 K to 210.2 K (-1.60 %) |
| Jan 03 2018 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.84 | 3,665 | 10,409 | 213,571 | 217.2 K to 213.6 K (-1.69 %) |
| Dec 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.00 | 3,212 | 9,636 | 217,236 | 220.4 K to 217.2 K (-1.46 %) |
| Nov 02 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.44 | 3,212 | 7,837 | 220,448 | 223.7 K to 220.4 K (-1.44 %) |
| Oct 02 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.86 | 3,212 | 9,186 | 223,660 | 226.9 K to 223.7 K (-1.42 %) |
| Sep 05 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.46 | 3,212 | 7,902 | 226,872 | 230.1 K to 226.9 K (-1.40 %) |
| Aug 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.29 | 2,869 | 6,570 | 230,084 | 233 K to 230.1 K (-1.23 %) |
| Jul 05 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.47 | 2,869 | 7,086 | 232,953 | 235.8 K to 233 K (-1.22 %) |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 2.32 | 15,000 | 34,800 | 15,000 | |
| Jun 16 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Grant | A | 0.00 | 10,000 | 0 | 235,822 | 225.8 K to 235.8 K (+4.43 %) |
| Jun 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 2.83 | 2,869 | 8,119 | 225,822 | 228.7 K to 225.8 K (-1.25 %) |
| May 01 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.33 | 2,869 | 9,554 | 228,691 | 231.6 K to 228.7 K (-1.24 %) |
| Apr 03 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.61 | 2,869 | 10,357 | 231,560 | 234.4 K to 231.6 K (-1.22 %) |
| Mar 03 2017 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Payment of Exercise | F | 3.54 | 32,927 | 116,562 | 234,429 | 267.4 K to 234.4 K (-12.32 %) |
| Dec 15 2016 | AVAN | Celldex Therapeuti ... | McMahon Gerald PhD | Director | Option Exercise | A | 3.72 | 8,000 | 29,760 | 8,000 | |
| Jun 03 2016 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 0.65 | 91,564 | 59,517 | 91,564 | |
| May 29 2015 | OXGN | OXIGENE INC | McMahon Gerald PhD | Director | Option Exercise | A | 1.43 | 77,996 | 111,534 | 77,996 | |
| Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.08 | 1,000,000 | 1,080,000 | 1,000,000 | |
| Jun 20 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.08 | 500,000 | 540,000 | 500,000 | |
| May 02 2006 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 1.25 | 250,000 | 312,500 | 250,000 | |
| Jan 25 2005 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 2.15 | 200,000 | 430,000 | 0 | |
| May 26 2004 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Buy | P | 2.75 | 5,000 | 13,750 | 5,000 | 0 to 5 K |
| May 20 2004 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 2.50 | 550,000 | 1,375,000 | 550,000 | |
| May 20 2004 | NERX | PONIARD PHARMACEUT ... | McMahon Gerald PhD | Chief Executive Off ... | Option Exercise | A | 2.50 | 550,000 | 1,375,000 | 550,000 |
Page: 1